Indeed, ERα36 was previously demonstrated to trigger (i) STAT3 signaling in mammary epithelial cells, (ii) MAPK signaling in breast cancer cells, and (iii) alkylphenol-dependent response in seminoma cells (13, 16, 46, 47). Here, STAT3 is linked to breast carcinoma.